Barclays Forecasts Strong Price Appreciation for Privia Health Group (NASDAQ:PRVA) Stock
Privia Health Group (NASDAQ:PRVA – Get Free Report) had its price objective lifted by investment analysts at Barclays from $23.00 to $24.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s target price indicates a potential upside of 4.03% from the company’s previous close. Other […]
Privia Health Group (NASDAQ:PRVA – Get Free Report) had its price objective lifted by investment analysts at Barclays from $23.00 to $24.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s target price indicates a potential upside of 4.03% from the company’s previous close. Other […]
